RxDoctor Payments DataLook up a doctor →

Asker Asmi, MD

Critical Care Medicine · Riverview, MINPI 1649240177

Payments from drug & device makers

$11,035in general payments, 2019–2025

Across 570 payments — averaging $19.36 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$2K
  • Mylan Specialty L.p.$1K
  • GSK$1K
  • Boehringer Ingelheim$1K
  • Grifols USA, LLC$654
  • Regeneron Healthcare Solutions, Inc.$392
  • plus $4K from 40 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$11,035 in reported general payments places this provider in the 90th percentile of 177 critical care medicine providers in Michigan.

See all critical care medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$277,691
Medicare patients
724
Services billed
2,434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other critical care medicine in Riverview

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →